SLRX Historical Earnings image   This SLRX historical earnings page last updated 5/23/2022
SLRX Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20225/12/2022NA
Q4 20213/10/2022NA
Q3 202111/4/2021NA
Q2 20218/5/20210.00B
Q1 20215/12/20210.00B
Q4 20203/18/20210.00B
Q3 202011/11/20200.00B
Q2 20208/12/20200.00B
Q1 20205/14/20200.00B
Q4 20193/23/20200.00B
Q3 201911/13/20190.00B
Q2 20197/17/20190.00B
Q1 20195/1/20190.00B
Q4 20183/6/20190.00B
Q3 201811/5/20180.00B
Q2 20188/1/20180.00B
Q1 20185/2/20180.00B
Q4 20173/7/20180.00B
Q3 201711/6/20170.00B
Q2 20178/2/20170.00B
Q1 20175/3/20170.00B
Q4 20163/8/20170.00B
Q3 201611/2/20160.00B
Q2 20168/3/20160.00B
Q1 20165/4/2016NA
Q4 20153/8/2016NA
Q3 201511/4/2015NA
Q2 20158/5/2015NA
Q1 20155/6/2015NA
FY 20143/17/2015NA
SLRX Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q1 20225/12/2022-0.130
Q4 20213/10/2022-0.090
Q3 202111/4/2021-0.080
Q2 20218/5/2021-0.070
Q1 20215/12/2021-0.060
Q4 20203/18/2021-0.100
Q3 202011/11/2020-0.100
Q2 20208/12/2020-0.130
Q1 20205/14/2020-0.220
Q4 20193/23/2020-0.440
Q3 201911/13/2019-0.730
Q2 20197/17/2019-2.000
Q1 20195/1/2019-3.000
Q4 20183/6/2019-2.750
Q3 201811/5/2018-3.750
Q2 20188/1/2018-12.500
Q1 20185/2/2018-11.500
Q4 20173/7/2018-11.500
Q3 201711/6/2017-13.500
Q2 20178/2/2017-12.750
Q1 20175/3/2017-12.250
Q4 20163/8/2017-12.000
Q3 201611/2/2016-16.250
Q2 20168/3/2016-17.750
Q1 20165/4/2016-15.250
Q4 20153/8/2016-12.750
Q3 201511/4/2015-13.250
Q2 20158/5/2015-11.750
Q1 20155/6/2015-14.750
FY 20143/17/2015-45.500
Quotes delayed 20 minutes

Email EnvelopeFree SLRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Salarius Pharmaceuticals (SLRX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

SLS Past Earnings
SMLR Past Earnings
SMMT Past Earnings
SMTI Past Earnings
SNDX Past Earnings
SNGX Past Earnings
SNOA Past Earnings
SNSE Past Earnings
SOLY Past Earnings
SONN Past Earnings
What was the record high SLRX historical earnings result?
In terms of earnings or revenue, what is the best SLRX historical earnings result that Salarius Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest SLRX historical earnings result was set in Q1 2021, when Salarius Pharmaceuticals posted results of -0.060/share. The most successful revenue quarter within our data set was Q4 2020 when Salarius Pharmaceuticals reported revenue of 0.00B.

What was the lowest Salarius Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest SLRX has reported, and when?

✔️Accepted answer: Within our data set, the lowest SLRX historical earnings result was set in FY 2014, when Salarius Pharmaceuticals posted results of -45.500/share. The smallest revenue quarter within our data set was Q1 2022 when Salarius Pharmaceuticals reported revenue of NA.

On this page we presented the SLRX historical earnings date information for Salarius Pharmaceuticals. Reviewing that SLRX Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2021, when SLRX posted gaap of -0.060/share. Meanwhile the lowest SLRX historical earnings result was in FY 2014, when SLRX posted gaap of -45.500/share. Moving to Salarius Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2020 when SLRX reported 0.00B in revenue, while the smallest revenue quarter was Q1 2022 when SLRX reported NA in revenue.

For self directed investors doing their due diligence on SLRX or any other given stock, their research can benefit from looking into all of the Salarius Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Salarius Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for SLRX. Thanks for visiting, and the next time you need to research SLRX historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: CTVA Options Chain, AUY Price Target, LGCY Options Chain.

 

SLRX Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.